Hikma Pharmaceuticals PLC - Back to Homepage
Hikma receives approval for Phenylephrine HCl Injection, USP

Hikma Pharmaceuticals PLC ("Hikma") (LSE: HIK) (NASDAQ Dubai: HIK), the fast growing multinational pharmaceutical group, today announces the approval of its New Drug Application...

Hikma launches argatroban injection

Hikma Pharmaceuticals PLC ("Hikma") (LSE: HIK) (NASDAQ Dubai: HIK), the fast growing multinational pharmaceutical group, is today updating the market on its current trading...

Hikma signs license and supply agreement with GP Pharm for its leading oncology compound

Hikma Pharmaceuticals PLC (“Hikma”) (LSE: HIK) (NASDAQ Dubai: HIK) today announces the signing of a license and supply agreement for the registration and marketing of Lutrate®...

Study proves 90 % success rate for Factive

Gemifloxacin Evaluation in treating Acute bacterial Rhino-Sinusitis (GEARS study) has been conducted and expected to be published in an international...

Hikma introduces Respirox to the Tunisian market

February 2010, Hikma Pharmaceuticals introduces Respirox; the Atypical antipsychotic, to Tunisian market. The active ingredient Risperidone is one of...

Hikma honored for its efforts to fight epilepsy

July 2009, Through a scientific meeting conducted in Jordan to discuss the latest updates in epilepsy, the Jordan Neurological Society honored Hikma...

Cloplav

Hikma conducted a pharmacodynamic study versus originator insuring the high quality of Cloplav in inhibiting platelet aggregation Hikma markets...

Actos

The most recent AACE treatment Guideline put TZD group (the group which actos belongs to) as the first line treatment option for type 2 Diabetic...

Hikma Pharmaceuticals PLC ("Hikma") (LSE: HIK) (NASDAQ Dubai: HIK), the fast growing multinational pharmaceutical group, today announces the approval of its New Drug Application...

Hikma Pharmaceuticals PLC ("Hikma") (LSE: HIK) (NASDAQ Dubai: HIK), the fast growing multinational pharmaceutical group, is today updating the market on its current trading...

Hikma Pharmaceuticals PLC (“Hikma”) (LSE: HIK) (NASDAQ Dubai: HIK) today announces the signing of a license and supply agreement for the registration and marketing of Lutrate®...

Gemifloxacin Evaluation in treating Acute bacterial Rhino-Sinusitis (GEARS study) has been conducted and expected to be published in an international...

February 2010, Hikma Pharmaceuticals introduces Respirox; the Atypical antipsychotic, to Tunisian market. The active ingredient Risperidone is one of...

July 2009, Through a scientific meeting conducted in Jordan to discuss the latest updates in epilepsy, the Jordan Neurological Society honored Hikma...

Hikma conducted a pharmacodynamic study versus originator insuring the high quality of Cloplav in inhibiting platelet aggregation Hikma markets...

The most recent AACE treatment Guideline put TZD group (the group which actos belongs to) as the first line treatment option for type 2 Diabetic...

  • Anesthetics

    HIKMA offers a comprehensive, high quality anesthesia portfolio including inhalational...

  • Anti-histamines

    Antihistamines (histamine H1 antagonists) are agents that serve to inhibit the release or action...

  • Anti-infectives

    The Infectious Disease (ID) class is one of the biggest therapeutic categories, resulting from...

  • Cardiovascular and diabetes

    The cardiovascular system is made up of the heart and blood vessels. Cardiovascular disease (CVD)...

  • Central nervous system

    Central Nervous System (CNS) therapeutic class is one of the largest categories with high level...

  • Gastroenterology and metabolism

    Gastroenterology & Metabolism Category concerns with food, nutrition & the digestion...

  • Musculoskeletal system

    Musculoskeletal disorders are one of the most common human afflictions health problems that may...

  • Dermatology

    Dermatology is the branch of medicine dealing with the skin and its diseases, a unique specialty...

  • Genitourinary system

    Genitourinary system is a system that includes aspects andrology, gynecology and urology and...

  • Hormones

    Hormone therapeutic class or hormonal therapy is the use of hormones (and hormone antagonists)...

  • Oncology

    Cancer remains one of the most feared diseases for patients and one of the key challenges for...

  • Respiratory system

    Respiratory diseases include diseases of the lung, pleural cavity, bronchial tubes, trachea,...

  • Transplantation

    Development achieved in the innovation of new immunosuppressive agents had given organ...

  • Vitamins and supplements

    Vitamins are essential substances needed for a body to grow and develop normally. Each vitamin...

Looking for a product?

View all products, or search for a product by entering
the name by which you know the product.

Search for products

Which Hikma products are available in your country?

Download a full list of Hikma products locally available

Our strengths

The success of our business reflects a commitment to excellence across all facets of our business.

Corporate responsibility

Corporate responsibility is and always has been an essential part of the Hikma way.

Our partners

View Hikma's partners or contact our business development department.